Zsurka, G.; Appel, M.L.T.; Nastaly, M.; Hallmann, K.; Hansen, N.; Nass, D.; Baumgartner, T.; Surges, R.; Hartmann, G.; Bartok, E.;
et al. Loss of the Immunomodulatory Transcription Factor BATF2 in Humans Is Associated with a Neurological Phenotype. Cells 2023, 12, 227.
https://doi.org/10.3390/cells12020227
AMA Style
Zsurka G, Appel MLT, Nastaly M, Hallmann K, Hansen N, Nass D, Baumgartner T, Surges R, Hartmann G, Bartok E,
et al. Loss of the Immunomodulatory Transcription Factor BATF2 in Humans Is Associated with a Neurological Phenotype. Cells. 2023; 12(2):227.
https://doi.org/10.3390/cells12020227
Chicago/Turabian Style
Zsurka, Gábor, Maximilian L. T. Appel, Maximilian Nastaly, Kerstin Hallmann, Niels Hansen, Daniel Nass, Tobias Baumgartner, Rainer Surges, Gunther Hartmann, Eva Bartok,
and et al. 2023. "Loss of the Immunomodulatory Transcription Factor BATF2 in Humans Is Associated with a Neurological Phenotype" Cells 12, no. 2: 227.
https://doi.org/10.3390/cells12020227
APA Style
Zsurka, G., Appel, M. L. T., Nastaly, M., Hallmann, K., Hansen, N., Nass, D., Baumgartner, T., Surges, R., Hartmann, G., Bartok, E., & Kunz, W. S.
(2023). Loss of the Immunomodulatory Transcription Factor BATF2 in Humans Is Associated with a Neurological Phenotype. Cells, 12(2), 227.
https://doi.org/10.3390/cells12020227